Kalkulators no Bio Protocol uz ASV dolārs
Viegli pārvērst Bio Protocol uz ASV dolārs ar mūsu kalkulatoru. Uzziniet konversijas attīstību un galvenās ekvivalences starp BIO un USD.
Kriptovalūtu konvertors
Bio Protocol uz USD — Tirgus dati
Tirgus kapitalizācija
$67,55 milj.
24h apjoms
$29,39 milj.
Maksimālais piedāvājums
3,32 mljrd.
Apgrozībā esošais piedāvājums
3,32 mljrd.
Tips
currency
Cena BIO/USD - Bio Protocol/Euro
Cenas Bio Protocol ir kāpj
Bio Protocol vērtība ir $0.0316. Proti, lai iegādātos 5 BIO, tev būs jāmaksā $0.1580. Savukārt, ar $1.00 tu varēsi iegādāties kopumā 31,64346872 BIO, kamēr $50.00 ļautu veikt pirkumu par 1582,17343578 BIO.
Pēdējo 7 dienu laikā Bio Protocol cena ir palielinājies par +12,07%. Savukārt pēdējās 24 stundās cena ir mainījusies par +4,90%.
Konversija BIO uz USD
| Daudzums | 12.06.2026 03:45 |
|---|---|
| 0.5 BIO | $0.0158 |
| 1 BIO | $0.0316 |
| 2 BIO | $0.0632 |
| 5 BIO | $0.1580 |
| 10 BIO | $0.3160 |
| 50 BIO | $1.58 |
| 100 BIO | $3.16 |
| 500 BIO | $15.80 |
| 1000 BIO | $31.60 |
Konversija USD uz BIO
| Daudzums | 12.06.2026 03:45 |
|---|---|
| $0.5000 | 0.01580105 BIO |
| $1.00 | 0.03160210 BIO |
| $2.00 | 0.06320420 BIO |
| $5.00 | 0.15801049 BIO |
| $10.00 | 0.31602098 BIO |
| $50.00 | 1.58010490 BIO |
| $100.00 | 3.16020980 BIO |
| $500.00 | 15.80104901 BIO |
| $1,000.00 | 31.60209802 BIO |
Iegādājieties Bio Protocol droši
Reģistrējieties Bit2Me un piekļūstiet visuzticamākajai kriptovalūtu apmaiņas platformai, lai droši iegādātos un pārdotu Bio Protocol.
Kas ir Bio Protocol?
Bio Protocol is a platform designed to accelerate scientific development through the decentralised funding and management of biotechnological projects. Its aim is to enable global communities of scientists, patients, and investors to collaborate on the creation and shared ownership of new drugs and therapies through decentralised autonomous organisations specialised in biotechnology, known as BioDAOs. The native token of Bio Protocol, called BIO, fulfils essential functions within the ecosystem. In addition to facilitating transactions, it grants its holders governance rights, allowing them to influence key decisions such as the selection of BioDAOs to support and the allocation of resources for the development of intellectual property assets. This approach seeks to democratise scientific research and encourage active community participation in biotechnological innovation.
